| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |